What is the price target for GNCA stock?
9 analysts have analysed GNCA and the average price target is 3.14 null. This implies a price increase of 6060% is expected in the next year compared to the current price of 0.051.
GENOCEA BIOSCIENCES INC (GNCA) Forecast, Price Target & Analyst Ratings
NASDAQ:GNCA • US3724274010
Current stock price
0.051
-0.01 (-15%)
At close:
0.055
+0 (+7.84%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GENOCEA BIOSCIENCES INC (GNCA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Jul 27, 2022
- Period
- Q2 / 2022
- EPS Estimate
- -$0.18
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.14
Upside
+ 6,060.00%
From current price of $0.05 to mean target of $3.14, Based on 9 analyst forecasts
Low
$0.16
Median
$3.14
High
$6.30
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for GNCA. The average price target is 3.14 null. This implies a price increase of 6060% is expected in the next year compared to the current price of 0.051.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
77.78%
GNCA was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about GNCA.
In the previous month the buy percentage consensus was at a similar level.
GNCA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-04-29 | Stifel | Downgrade | Buy -> Hold |
| 2022-04-29 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-04-06 | SVB Leerink | Maintains | Outperform |
| 2021-02-11 | Needham | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jul 27, 2022
- Period
- Q2 / 2022
- EPS Estimate
- -$0.18
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- -206.00%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
GNCA is expected to report earnings on 7/27/2022. The consensus EPS estimate for the next earnings is -0.18 null and the consensus revenue estimate is 0 null.
Full Analyst Estimates 2022 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.36M | 1.64M 20.59% | 578.003K -64.76% | -100.00% | |||||
| EBITDA YoY % growth | -37.89M 1.41% | -45.85M -21.01% | -50.53M -10.21% | -57.936M -14.66% | -62.526M -7.92% | -52.871M 15.44% | -45.601M 13.75% | N/A | |
| EBIT YoY % growth | -38.99M 1.34% | -46.99M -20.52% | -52.09M -10.85% | -42.84M 17.76% | -67.218M -56.90% | -56.985M 15.22% | -44.224M 22.39% | -35.008M 20.84% | |
| Operating Margin | N/A | -3,455.15% | -3,176.22% | -7,411.72% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -2.24 20.00% | -1.16 48.21% | -0.47 59.48% | -0.74 -58.43% | -0.85 -13.70% | -0.56 33.73% | -0.61 -7.86% | -0.67 -10.02% |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 -206.00% | -0.18 -267.20% | -0.19 -2.00% | -0.19 11.91% | -0.19 -5.56% | -0.20 -11.11% | -0.20 -5.26% |
| Revenue Q2Q % growth | -100.00% | -100.00% | |||||
| EBITDA Q2Q % growth | -13.974M -1.26% | -14.586M -37.99% | -15.504M -30.84% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.67M 40.41% | -12.954M -10.53% | -12.954M 3.40% | -13.464M 14.62% | -13.464M -55.29% | -14.28M -10.24% | -14.28M -10.24% |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-6.08%
EPS Next 5 Year
-7.21%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-14.87%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
GENOCEA BIOSCIENCES INC / GNCA Forecast FAQ
When does GENOCEA BIOSCIENCES INC (GNCA) report earnings?
GENOCEA BIOSCIENCES INC (GNCA) will report earnings on 2022-07-27.
Can you provide the consensus estimates for GENOCEA BIOSCIENCES INC next earnings?
The consensus EPS estimate for the next earnings of GENOCEA BIOSCIENCES INC (GNCA) is -0.18 null and the consensus revenue estimate is 0 null.
Can you provide the consensus rating for GENOCEA BIOSCIENCES INC stock?
The consensus rating for GENOCEA BIOSCIENCES INC (GNCA) is 77.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.